SIONNA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
SIONNA THERAPEUTICS, INC. (SION) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.12 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- SIONNA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 313.72K shares, a 11.92% decline year-over-year.
- SIONNA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.81M shares, a 7.29% decline year-over-year.
- SIONNA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 328.20K shares.
- SIONNA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 91.20K shares.
- SIONNA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 2.73M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 313.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 2.12M shares 10-Q · filed 2026-08-06 | 2.45M shares derived: sum of 3 quarters · filed 2026-08-06 | 2.54M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 1.81M shares 10-Q · filed 2026-05-12 | 2.14M shares derived: sum of 2 quarters · filed 2026-05-12 | 2.23M shares derived: sum of 3 quarters · filed 2026-05-12 | 2.58M shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 328.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 419.40K shares derived: sum of 2 quarters · filed 2026-03-02 | 775.57K shares derived: sum of 3 quarters · filed 2026-03-02 | 2.73M shares 10-K · filed 2026-03-02 |
| 2025-09-30 | 91.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 447.37K shares derived: sum of 2 quarters · filed 2025-11-05 | 2.40M shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 356.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 2.31M shares 10-Q · filed 2025-08-11 | ||
| 2025-03-31 | 1.95M shares 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |